Tag: board

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, announced today the appointment of Dieter Weinand as Chair of the Board of Directors, effective June 12, 2025. Mr. Weinand is the former Chief Executive Officer of Bayer Pharma AG with more than 25 years of experience as a senior business leader in the pharmaceutical industry. He takes over from Dr. Jeanne Bolger, who served as Chair since 2022 and will remain on the Board as a non-executive independent director.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BigBear.ai Holdings, Inc. (NYSE:BBAI) on behalf of long-term stockholders following a class action complaint that was filed against BigBear on April 11, 2025 with a Class Period from March 31, 2022 through March 25, 2025. Our investigation concerns whether the board of directors of BigBear have breached their fiduciary duties to the company.

TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Marrelli Capital Limited, a company that Carmelo Marrelli (the “Acquiror”), the CEO of BE Resources Inc. (the “Company”), exercises control and direction over, announces today that it has filed an early warning report in respect of its holdings in the Company. On June 11, 2025, the Acquiror acquired 769,230 common shares of the Company (the “Shares”) by way of private agreement (the “Acquisition”) with a third-party vendor.